DKP21102_A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DKP21102_A, covering 2024-10-24 to 2024-10-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A [Phase 3]